- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03021746
Fostering Sustainability Through Diabetes Self-Management Support
December 15, 2021 updated by: Gretchen Piatt, University of Michigan
To understand the effectiveness of three approaches to address diabetes self-management support compared to enhanced usual care in church-based settings.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To understand the effectiveness of three approaches to address diabetes self-management support compared to enhanced usual care in church-based settings.
Study Type
Interventional
Enrollment (Actual)
358
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have Type 2 diabetes for at least 6 months
- Be Black/African American
- Be a resident of metro-Detroit, Toledo, or Flint
- Be at least 21 years old
- Be under the care of a physician for diabetes
- Have transportation to attend the program
Exclusion Criteria:
- Have Type 2 diabetes for less than 6 months
- Under 21 years of age
- Not under care of physician
- Lack of transportation to attend the program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Parish Nurse plus Peer Leader
The focus of this approach is for Peer Leaders (PL) to provide Diabetes Self Management Support (DSMS) with the oversight of Parish Nurses (PN).
The first component starts with group-based Diabetes Self Management Education (DSME) provided by Certified Diabetes Educators (CDE), co-facilitated by PN and PL and held at the church.
PL will also facilitate activities including behavioral goal setting, monthly phone contacts, and preparation for a diabetes-related health care visit, with oversight of PN.
As the study progresses, PL and PN will have progressive leadership responsibilities.
Following DSME, participants will be invited to attend 12 months of monthly DSMS support groups led by the PL, with oversight from the PN.
This approach allows for PN to provide direct supervision to PL in areas of clinical content, educational methods, and group facilitation and communication skills.
|
|
|
Experimental: Peer Leader Only
This approach will contain the same elements as the PN plus PL approach, except that a PN will not be used.
Rather, PL will provide all aspects of DSMS, including behavioral goal setting, monthly phone contacts, and preparation for a diabetes-related health care visit.
This approach will be delivered in a group setting.
DSME will be provided by CDEs and co-facilitated by a PL to ensure consistency in the DSME content.
Following DSME, participants will be invited to attend 12 monthly DSMS groups led by PL.
Following the group sessions, participants will transition into a period of ongoing support.
During this time, participants and PL will be encouraged to foster DSMS through programs and initiatives that are meaningful to them, utilizing the existing church infrastructure.
If needed, PL may contact the CDE for additional information
|
|
|
Experimental: Parish Nurse Only
The main focus of this approach will contain all of the same elements as the PN plus PL approach, except that PL will not be used.
Rather, the PN will provide all aspects of Diabetes Self Management Support (DSMS), including facilitation of goal setting, monthly phone contacts, and preparation for a diabetes-related health care visit.
Diabetes Self Management Education (DSME) will be provided by CDEs and co-facilitated by a PN to ensure consistency in the DSME content.
Following DSME, participants will be invited to attend 12 months of monthly, DSMS support groups led by the PN.
Following support sessions, participants will transition into a period of ongoing support, where the participants and PN will be encouraged to continue to foster DSMS through programs and initiatives that are meaningful to them, utilizing the existing church infrastructure.
The PN may answer clinical questions and may contact the CDE for additional information if needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in A1C Blood Glucose level
Time Frame: During this study, A1c will be measured at five time points; baseline, 6 months, 9 months, 21 months, and 33 months.
|
An A1C test is a blood test that reflects one's average blood glucose levels over the previous 3 months.
|
During this study, A1c will be measured at five time points; baseline, 6 months, 9 months, 21 months, and 33 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gretchen Piatt, MPH, PhD, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2016
Primary Completion (Actual)
August 31, 2021
Study Completion (Actual)
August 31, 2021
Study Registration Dates
First Submitted
January 12, 2017
First Submitted That Met QC Criteria
January 12, 2017
First Posted (Estimate)
January 16, 2017
Study Record Updates
Last Update Posted (Actual)
December 16, 2021
Last Update Submitted That Met QC Criteria
December 15, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00104965
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and Digestive...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Leiden University Medical CenterAndaluz Health ServiceCompletedDiabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes MellitusNetherlands, Spain
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
Clinical Trials on Diabetes Self Management Support (DSMS)
-
University of MichiganActive, not recruiting
-
University of ArkansasPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2United States
-
American Association of Diabetes EducatorsBristol-Myers SquibbUnknownDiabetes Mellitus Type 2United States
-
University of MichiganNational Institutes of Health (NIH); National Institute on Aging (NIA); Blue...Completed
-
Universidad de AntioquiaCompletedDiabetes Mellitus, Type 2Colombia
-
Selcuk UniversityCompletedType 2 Diabetes Mellitus (T2DM)Turkey (Türkiye)
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of CincinnatiNot yet recruitingDiabetes Mellitus, Type 2 | PreDiabetesUnited States
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); New...CompletedType 2 DiabetesUnited States
-
State University of New York - Upstate Medical...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed